{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:27Z","timestamp":1787032827820,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,13]]},"DOI":"10.7759\/cureus.94512","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T06:09:26Z","timestamp":1760422166000},"source":"Crossref","is-referenced-by-count":1,"title":["Immunohistochemical Evaluation of Phosphatase and Tensin Homolog (PTEN) Expression in Endometrial Lesions: A Cross-Sectional Study in a Tertiary Care Center in South India"],"prefix":"10.7759","author":[{"given":"Sanjana","family":"Pamidimukkala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srismitha","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. S. Gayathri","family":"Priyadarshini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Consensus document for management of uterine cancer. (2018). Accessed. July 03, 2025: https:\/\/www.icmr.gov.in\/icmrobject\/custom_data\/pdf\/resource-guidelines\/Uterine_Cancer.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30090574","article-title":"An overview of endometrial cancer with novel therapeutic strategies","volume":"30","author":"Kuhn TM","year":"2023","unstructured":"Kuhn TM, Dhanani S, Ahmad S. An overview of endometrial cancer with novel therapeutic strategies. Curr Oncol. 2023, 30:7904-19. 10.3390\/curroncol30090574","journal-title":"Curr Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw042","article-title":"New concepts for an old problem: the diagnosis of endometrial hyperplasia","volume":"23","author":"Sanderson PA","year":"2017","unstructured":"Sanderson PA, Critchley HO, Williams AR, Arends MJ, Saunders PT. New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum Reprod Update. 2017, 23:232-54. 10.1093\/humupd\/dmw042","journal-title":"Hum Reprod Update"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/00313020601136153","article-title":"Endometrial carcinoma: pathology and genetics","volume":"39","author":"Prat J","year":"2007","unstructured":"Prat J, Gallardo A, Cuatrecasas M, Catas\u00fas L. Endometrial carcinoma: pathology and genetics. Pathology. 2007, 39:72-87. 10.1080\/00313020601136153","journal-title":"Pathology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-005-1109-5","article-title":"Endometrial cancer","volume":"322","author":"Ryan AJ","year":"2005","unstructured":"Ryan AJ, Susil B, Jobling TW, Oehler MK. Endometrial cancer. Cell Tissue Res. 2005, 322:53-61. 10.1007\/s00441-005-1109-5","journal-title":"Cell Tissue Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman JV","year":"1983","unstructured":"Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983, 15:10-7. 10.1016\/0090-8258(83)90111-7","journal-title":"Gynecol Oncol"},{"key":"ref7","article-title":"Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies","volume":"57","author":"Tashiro H","year":"1997","unstructured":"Tashiro H, Blazes MS, Wu R, et al.. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 1997, 57:3935-40.","journal-title":"Cancer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10434","article-title":"Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma","volume":"94","author":"Salvesen HB","year":"2002","unstructured":"Salvesen HB, Stefansson I, Kalvenes MB, Das S, Akslen LA. Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma. Cancer. 2002, 94:2185-91. 10.1002\/cncr.10434","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2620","article-title":"High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma","volume":"65","author":"Oda K","year":"2005","unstructured":"Oda K, Stokoe D, Taketani Y, McCormick F. High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma. Cancer Res. 2005, 65:10669-73. 10.1158\/0008-5472.CAN-05-2620","journal-title":"Cancer Res"},{"key":"ref10","article-title":"PTEN\/MMAC1 mutations in endometrial cancers","volume":"57","author":"Risinger JI","year":"1997","unstructured":"Risinger JI, Hayes AK, Berchuck A, Barrett JC. PTEN\/MMAC1 mutations in endometrial cancers. Cancer Res. 1997, 57:4736-8.","journal-title":"Cancer Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"92","author":"Mutter GL","year":"2000","unstructured":"Mutter GL, Lin MC, Fitzgerald JT, et al.. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst. 2000, 92:924-30. 10.1093\/jnci\/92.11.924","journal-title":"J Natl Cancer Inst"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.208","article-title":"Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing","volume":"25","author":"Djordjevic B","year":"2012","unstructured":"Djordjevic B, Hennessy BT, Li J, Barkoh BA, Luthra R, Mills GB, Broaddus RR. Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing. Mod Pathol. 2012, 25:699-708. 10.1038\/modpathol.2011.208","journal-title":"Mod Pathol"},{"key":"ref13","article-title":"Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review","volume":"11","author":"Kaaks R","year":"2002","unstructured":"Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002, 11:1531-43.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-003-0947-3","article-title":"Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification","volume":"444","author":"Lax SF","year":"2004","unstructured":"Lax SF. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch. 2004, 444:213-23. 10.1007\/s00428-003-0947-3","journal-title":"Virchows Arch"},{"key":"ref15","unstructured":"American Cancer Society. Cancer Facts & Figures. (2024). Accessed. August 25, 2025: https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/2024-cancer-facts-figures.html."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2006.00541.x","article-title":"Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium","volume":"16","author":"Erkanli S","year":"2006","unstructured":"Erkanli S, Kayaselcuk F, Kuscu E, Bagis T, Bolat F, Haberal A, Demirhan B. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium. Int J Gynecol Cancer. 2006, 16:1412-8. 10.1111\/j.1525-1438.2006.00541.x","journal-title":"Int J Gynecol Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","author":"Setiawan VW","year":"2013","unstructured":"Setiawan VW, Yang HP, Pike MC, et al.. Type I and II endometrial cancers: have they different risk factors?. J Clin Oncol. 2013, 31:2607-18. 10.1200\/JCO.2012.48.2596","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232231","article-title":"Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: a\u00a0systematic review and meta-analysis","volume":"15","author":"Doherty MT","year":"2020","unstructured":"Doherty MT, Sanni OB, Coleman HG, et al.. Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: a\u00a0systematic review and meta-analysis. PLoS One. 2020, 15:e0232231. 10.1371\/journal.pone.0232231","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Trimble CL","year":"2006","unstructured":"Trimble CL, Kauderer J, Zaino R, et al.. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006, 106:812-9. 10.1002\/cncr.21650","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer","volume":"366","author":"Amant F","year":"2005","unstructured":"Amant F, Moerman P, Neven P, et al.. Endometrial cancer. Lancet. 2005, 366:491-505. 10.1016\/S0140-6736(05)67063-8","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.881850","article-title":"Association of tumor size with myometrial invasion, lymphovascular space invasion, lymph node metastasis, and recurrence in endometrial cancer: a meta-analysis of 40 studies with 53,276 patients","volume":"12","author":"Jin X","year":"2022","unstructured":"Jin X, Shen C, Yang X, Yu Y, Wang J, Che X. Association of tumor size with myometrial invasion, lymphovascular space invasion, lymph node metastasis, and recurrence in endometrial cancer: a meta-analysis of 40 studies with 53,276 patients. Front Oncol. 2022, 12:881850. 10.3389\/fonc.2022.881850","journal-title":"Front Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-4-41","article-title":"Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium","volume":"4","author":"Sarmadi S","year":"2009","unstructured":"Sarmadi S, Izadi-Mood N, Sotoudeh K, Tavangar SM. Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium. Diagn Pathol. 2009, 4:41. 10.1186\/1746-1596-4-41","journal-title":"Diagn Pathol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2670","article-title":"BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression","volume":"11","author":"Feng YZ","year":"2005","unstructured":"Feng YZ, Shiozawa T, Miyamoto T, Kashima H, Kurai M, Suzuki A, Konishi I. BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression. Clin Cancer Res. 2005, 11:6133-8. 10.1158\/1078-0432.CCR-04-2670","journal-title":"Clin Cancer Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.111","article-title":"Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma","volume":"25","author":"Lee H","year":"2012","unstructured":"Lee H, Choi HJ, Kang CS, Lee HJ, Lee WS, Park CS. Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma. Mod Pathol. 2012, 25:1508-15. 10.1038\/modpathol.2012.111","journal-title":"Mod Pathol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-200304000-00005","article-title":"Loss of expression of MLH1, MSH2, MSH6, and PTEN related to endometrial cancer in 68 patients with endometrial hyperplasia","volume":"22","author":"Orbo A","year":"2003","unstructured":"Orbo A, Nilsen MN, Arnes MS, Pettersen I, Larsen K. Loss of expression of MLH1, MSH2, MSH6, and PTEN related to endometrial cancer in 68 patients with endometrial hyperplasia. Int J Gynecol Pathol. 2003, 22:141-8. 10.1097\/00004347-200304000-00005","journal-title":"Int J Gynecol Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/424229-immunohistochemical-evaluation-of-phosphatase-and-tensin-homolog-pten-expression-in-endometrial-lesions-a-cross-sectional-study-in-a-tertiary-care-center-in-south-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T06:09:29Z","timestamp":1760422169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/424229-immunohistochemical-evaluation-of-phosphatase-and-tensin-homolog-pten-expression-in-endometrial-lesions-a-cross-sectional-study-in-a-tertiary-care-center-in-south-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.94512","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,13]]}}}